Humana AB EBITDA vs. Cash Per Share

HUM Stock  SEK 36.75  0.30  0.82%   
Based on the measurements of profitability obtained from Humana AB's financial statements, Humana AB may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Humana AB's ability to earn profits and add value for shareholders.
For Humana AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Humana AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Humana AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Humana AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Humana AB over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Humana AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Humana AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Humana AB Cash Per Share vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Humana AB's current stock value. Our valuation model uses many indicators to compare Humana AB value to that of its competitors to determine the firm's financial worth.
Humana AB is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in cash per share category among its peers . The ratio of EBITDA to Cash Per Share for Humana AB is about  99,130,435 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Humana AB's earnings, one of the primary drivers of an investment's value.

Humana Cash Per Share vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Humana AB

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
912 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Humana AB

Cash Per Share

 = 

Total Cash

Average Shares

 = 
9.20 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Humana Cash Per Share Comparison

Humana AB is currently under evaluation in cash per share category among its peers.

Humana AB Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Humana AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Humana AB will eventually generate negative long term returns. The profitability progress is the general direction of Humana AB's change in net profit over the period of time. It can combine multiple indicators of Humana AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Humana AB , together with its subsidiaries, provides individual and family care services for children, adolescents, and adults in Sweden, Norway, Denmark, and Finland. Humana AB was founded in 2001 and is headquartered in Stockholm, Sweden. Humana AB operates under Personal Services classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11238 people.

Humana Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Humana AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Humana AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Humana AB's important profitability drivers and their relationship over time.

Use Humana AB in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Humana AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humana AB will appreciate offsetting losses from the drop in the long position's value.

Humana AB Pair Trading

Humana AB Pair Trading Analysis

The ability to find closely correlated positions to Humana AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Humana AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Humana AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Humana AB to buy it.
The correlation of Humana AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Humana AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Humana AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Humana AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Humana AB position

In addition to having Humana AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Precious Metals Funds Thematic Idea Now

Precious Metals Funds
Precious Metals Funds Theme
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Humana Stock Analysis

When running Humana AB's price analysis, check to measure Humana AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana AB is operating at the current time. Most of Humana AB's value examination focuses on studying past and present price action to predict the probability of Humana AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana AB's price. Additionally, you may evaluate how the addition of Humana AB to your portfolios can decrease your overall portfolio volatility.